132 related articles for article (PubMed ID: 1309180)
1. Drug treatment of panic disorder. Reply to comment by Marks and associates.
Klerman GL
Br J Psychiatry; 1992 Oct; 161():465-71. PubMed ID: 1309180
[No Abstract] [Full Text] [Related]
2. Upjohn answers Consumer Reports.
Olanoff LS
J Clin Psychopharmacol; 1993 Oct; 13(5):361-3. PubMed ID: 8227495
[No Abstract] [Full Text] [Related]
3. Method for assessing the duration of therapeutic action and milligram equivalence of anxiolytics.
Sheehan DV; Raj AB; Harnett-Sheehan K; Dorotheo J; Sheehan MF; Trehan R; Knapp E; Swiontek A; Coleman B
Anxiety; 1996; 2(1):40-6. PubMed ID: 9160598
[No Abstract] [Full Text] [Related]
4. Upjohn responds to Consumer Reports letter.
Jonas JM
J Clin Psychopharmacol; 1994 Aug; 14(4):289-90; author reply 291-2. PubMed ID: 7962694
[No Abstract] [Full Text] [Related]
5. Psychopharmacological treatment of panic disorder and related states: a placebo controlled study of alprazolam.
Swinson RP; Pecknold JC; Kuch K
Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):105-13. PubMed ID: 3628823
[TBL] [Abstract][Full Text] [Related]
6. Treatment of panic disorder.
Cassano GB; Toni C; Musetti L
Adv Biochem Psychopharmacol; 1992; 47():449-60. PubMed ID: 1509926
[No Abstract] [Full Text] [Related]
7. Safety and side-effects of alprazolam. Controlled study in agoraphobia with panic disorder.
O'Sullivan GH; Noshirvani H; Başoğlu M; Marks IM; Swinson R; Kuch K; Kirby M
Br J Psychiatry; 1994 Jul; 165(1):79-86. PubMed ID: 7802851
[TBL] [Abstract][Full Text] [Related]
8. A controlled study of alprazolam and propranolol in panic-disordered and agoraphobic outpatients.
Ravaris CL; Friedman MJ; Hauri PJ; McHugo GJ
J Clin Psychopharmacol; 1991 Dec; 11(6):344-50. PubMed ID: 1770152
[TBL] [Abstract][Full Text] [Related]
9. Personality dimensions in panic disorder before and after effective treatment.
Starcevic V; Uhlenhuth EH
Anxiety; 1996; 2(2):95-8. PubMed ID: 9160608
[No Abstract] [Full Text] [Related]
10. Alprazolam plasma concentrations and treatment response in panic disorder and agoraphobia.
Lesser IM; Lydiard RB; Antal E; Rubin RT; Ballenger JC; DuPont R
Am J Psychiatry; 1992 Nov; 149(11):1556-62. PubMed ID: 1415824
[TBL] [Abstract][Full Text] [Related]
11. Alprazolam in panic disorder: a retrospective analysis.
Shelton RC; Harvey DS; Stewart PM; Loosen PT
Prog Neuropsychopharmacol Biol Psychiatry; 1993 May; 17(3):423-34. PubMed ID: 8475324
[TBL] [Abstract][Full Text] [Related]
12. Plasma alprazolam concentrations. Relation to efficacy and side effects in the treatment of panic disorder.
Greenblatt DJ; Harmatz JS; Shader RI
Arch Gen Psychiatry; 1993 Sep; 50(9):715-22. PubMed ID: 8357297
[TBL] [Abstract][Full Text] [Related]
13. Behavioural aggression in panic disorder after 8 weeks' treatment with alprazolam.
Bond AJ; Curran HV; Bruce MS; O'Sullivan G; Shine P
J Affect Disord; 1995 Dec; 35(3):117-23. PubMed ID: 8749839
[TBL] [Abstract][Full Text] [Related]
14. Switching patients from alprazolam to clonazepam.
Rosenbaum JF
Hosp Community Psychiatry; 1990 Dec; 41(12):1302, 1305. PubMed ID: 2276722
[No Abstract] [Full Text] [Related]
15. Discontinuation reactions to alprazolam in panic disorder.
Pecknold JC
J Psychiatr Res; 1993; 27 Suppl 1():155-70. PubMed ID: 8145176
[TBL] [Abstract][Full Text] [Related]
16. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety.
Noyes R; DuPont RL; Pecknold JC; Rifkin A; Rubin RT; Swinson RP; Ballenger JC; Burrows GD
Arch Gen Psychiatry; 1988 May; 45(5):423-8. PubMed ID: 3358644
[TBL] [Abstract][Full Text] [Related]
17. Avoidance behaviour: a predictor of the efficacy of pharmacotherapy in panic disorder?
Maier W; Roth SM; Argyle N; Buller R; Lavori P; Brandon S; Benkert O
Eur Arch Psychiatry Clin Neurosci; 1991; 241(3):151-8. PubMed ID: 1790160
[TBL] [Abstract][Full Text] [Related]
18. Relationship of panic, anticipatory anxiety, agoraphobia and global improvement in panic disorder with agoraphobia treated with alprazolam and exposure.
Başoğlu M; Marks IM; Kiliç C; Swinson RP; Noshirvani H; Kuch K; O'Sullivan G
Br J Psychiatry; 1994 May; 164(5):647-52. PubMed ID: 7921715
[TBL] [Abstract][Full Text] [Related]
19. The 'efficacy' of alprazolam in panic disorder and agoraphobia: a critique of recent reports.
Marks IM; De Albuquerque A; Cottraux J; Gentil V; Greist J; Hand I; Liberman RL; Relvas JS; Tobeña A; Tyrer P
Arch Gen Psychiatry; 1989 Jul; 46(7):668-72. PubMed ID: 2660772
[No Abstract] [Full Text] [Related]
20. A fixed-dose study of alprazolam 2 mg, alprazolam 6 mg, and placebo in panic disorder.
Lydiard RB; Lesser IM; Ballenger JC; Rubin RT; Laraia M; DuPont R
J Clin Psychopharmacol; 1992 Apr; 12(2):96-103. PubMed ID: 1573046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
